The UK government has said it will end the NHS's controversial contract with US tech firm Palantir, but not until 2029 – two ...
Real-World Evidence for the Impact of Company-Led Medical Education – Medscape Medical Affairs explores the question of ...
Access and clarity should not be treated as separate problems. When organisations treat clarity as part of access, they ...
Novo has published the results of a clinical trial of its Wegovy injection in children aged six to 12 with obesity, showing ...
Novo Nordisk has said a real-world survey of its weight-loss therapy Wegovy shows it can reduce 'food noise', persistent, intrusive, or repetitive thoughts about eating – even when full – that can be ...
Helus Pharma has revealed data from a phase 3 trial of HLP003 that showed evidence of efficacy in major depressive disorder ...
The FDA has said it cannot approve Summit Therapeutics and Akeso's PD-1xVEGF inhibitor ivonescimab, delaying a drug that is ...
New Orleans hosted this year’s AAPS PharmSci 360 at the Ernest N. Morial Convention Center. For those fortunate enough to ...
Eli Lilly has added yet another name to its list of M&A deals this year after agreeing to buy blood disorder specialist Calytrix Bio for up to $1.5 billion. If it goes through, the deal will give ...
AstraZeneca's rare disease unit Alexion has won regulatory approval in the US and EU for Klygefa as a generalised myasthenia ...
Just a few months after being formed, China's Funnel Biosciences has signed a $2 billion-plus partnership with Third Rock ...
Asundexian has been approved by the FDA under the Sunharbo brand name for use in combination with antiplatelet therapy to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results